Acadian Asset Management
BDSX icon

Acadian Asset Management’s Biodesix BDSX Stock Holding History

Acadian Asset Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-927
Closed -$42K – 1749
2022
Q4 		$42K Buy
+927
New +$25.2K ﹤0.01% 1599

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Acadian Asset Management's BDSX Position: Q1 2023 in Review

Acadian Asset Management sold out of Biodesix (BDSX) in Q1 2023, closing a stake of 927 shares — an estimated $42K sold.

Acadian Asset Management first reported a position in BDSX in Q4 2022 and held it in 1 quarter. The position peaked at $42K in Q4 2022. 30 funds tracked by Wall St. Rank hold BDSX as of Q1 2023.

  • Acadian Asset Management reported no remaining Biodesix position as of Q1 2023 after selling out during the quarter.
  • Acadian Asset Management sold 927 Biodesix shares in Q1 2023, an estimated $42K.
  • Acadian Asset Management first reported a position in Biodesix in Q4 2022 and held it in 1 quarter.
  • Acadian Asset Management's Biodesix position peaked at $42K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Biodesix as of Q1 2023.

Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.